Publications | Lund University Publications

1 – 10 of 11

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hellstr%C3%B6m%2C+Mats%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hellstr%C3%B6m%2C+Mats%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2022
Mark Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed : The Study Protocol for the Randomized Controlled NEEDS Trial
Nilsson, Magnus ; Olafsdottir, Halla ; Alexandersson von Döbeln, Gabriella ; Villegas, Fernanda ; Gagliardi, Giovanna ; Hellström, Mats ; Wang, Qiao-Li ; Johansson, Hemming ; Gebski, Val and Hedberg, Jakob , et al. (2022) In Frontiers in Oncology 12.
- Contribution to journal › Article
2021
Mark Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients with ERBB2-Positive Breast Cancer : A Phase 2 Randomized Clinical Trial
Hatschek, Thomas ; Foukakis, Theodoros ; Bjöhle, Judith ; Lekberg, Tobias ; Fredholm, Hanna ; Elinder, Ellinor ; Bosch, Ana ; Pekar, Gyula ^LU ; Lindman, Henrik and Schiza, Aglaia , et al. (2021) In JAMA Oncology 7(9). p.1360-1367
- Contribution to journal › Article
2020
Mark Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
Papakonstantinou, Antroula ; Matikas, Alexios ; Bengtsson, Nils Olof ; Malmström, Per ^LU ; Hedayati, Elham ; Steger, Guenther ; Untch, Michael ; Hübbert, Laila ; Johansson, Hemming and Hellström, Mats , et al. (2020) In Cancer 126(6). p.1175-1182
- Contribution to journal › Article
2019
Mark Intestinal preservation injury : A comparison between rat, porcine and human intestines
Søfteland, John Mackay ; Casselbrant, Anna ; Biglarnia, Ali Reza ; Linders, Johan ^LU ; Hellström, Mats ; Pesce, Antonio ; Padma, Arvind Manikantan ; Jiga, Lucian Petru ; Hoinoiu, Bogdan and Ionac, Mihai , et al. (2019) In International Journal of Molecular Sciences 20(13).
- Contribution to journal › Article
2018
Mark Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
Matikas, Alexios ; Margolin, Sara ; Hellström, Mats ; Johansson, Hemming ; Bengtsson, Nils Olof ; Karlsson, Lena ; Edlund, Per ; Karlsson, Per ; Lidbrink, Elisabet and Linderholm, Barbro , et al. (2018) In Breast Cancer Research and Treatment 168(2). p.349-355
- Contribution to journal › Article
Mark Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
Kimbung, Siker ^LU ; Markholm, Ida ; Bjöhle, Judith ; Lekberg, Tobias ; Wachenfeldt, von Anna ; Azavedo, Edward ; Saracco, Ariel ; Hellström, Mats ; Veerla, Srinivas ^LU and Paquet, Eric , et al. (2018) In International Journal of Cancer 142(3). p.618-628
- Contribution to journal › Article
2016
Mark Effect of tailored dose-dense chemotherapy vs standard 3-weekly adjuvant chemotherapy on recurrence-free survival among women with high-risk early breast cancer : A randomized clinical trial
Foukakis, Theodoros ; Von Minckwitz, Gunter ; Bengtsson, Nils Olof ; Brandberg, Yvonne ; Wallberg, Birgitta ; Fornander, Tommy ; Mlineritsch, Brigitte ; Schmatloch, Sabine ; Singer, Christian F. and Steger, Günther , et al. (2016) In JAMA: The Journal of the American Medical Association 316(18). p.1888-1896
- Contribution to journal › Article
2015
Mark Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
Mansouri, Larry ; Sutton, Lesley-Ann ; Ljungström, Viktor ; Bondza, Sina ; Arngården, Linda ; Bhoi, Sujata ; Larsson, Jimmy ; Cortese, Diego ; Kalushkova, Antonia and Plevova, Karla , et al. (2015) In Journal of Experimental Medicine 212(6). p.833-843
- Contribution to journal › Article
2011
Mark A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
Margolin, Sara ; Bengtsson, Nils-Olof ; Carlsson, Lena ; Edlund, Per ; Hellstrom, Mats ; Karlsson, Per ; Lidbrink, Elisabet ; Linderholm, Barbro ; Lindman, Henrik and Malmström, Per ^LU , et al. (2011) In Acta Oncologica 50(1). p.35-41
- Contribution to journal › Article
1999
Mark Role of platelet-derived growth factors in angiogenesis and alveogenesis.
Lindahl, Per ; Ehrencrona, Hans ^LU ; Karlsson, Linda ; Hellström, Mats ; Kalén, Mattias and Betsholtz, Christer (1999) In Current topics in pathology. Ergebnisse der Pathologie 93. p.27-33
- Contribution to journal › Scientific review

« previous
1
2
next »

your query:: Remove author: Hellström, Mats